VANCOUVER--(BUSINESS WIRE)--Ross Senior, President and CEO of ProtoKinetix Inc. (PKTX), announces the formation of a Joint Venture with Zymes LLC to commercialize a unique new product line. Zymes is a world leader in the production of high quality Co-enzyme Q10, a well recognized and potent anti-oxidant. Zymes’ Co-founder and Chief Scientific Officer, Dr. Bruce Lipshutz, has patented a method for producing water soluble CoQ10 (The Lipshutz Method) which has been proven to increase the absorption into cells and tissues for protection and repair. This Joint Venture will combine the knowledge and expertise of two world renowned sciences from France (Dr. Geraldine Deliencourt) and the United States (Prof. Bruce Lipshutz, U of C, Santa Barbara).
